Clare Mc Cabe
About Clare Mc Cabe
Clare Mc Cabe is the Executive Director of Worldwide Commercialization for Opdivo & Yervoy Melanoma and Opdualag at Bristol Myers Squibb, with over a decade of experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Clare Mc Cabe currently holds the position of Executive Director, Worldwide Commercialization for Opdivo & Yervoy Melanoma and Opdualag at Bristol Myers Squibb. Based in the United States, she plays a crucial role in the global marketing and commercialization strategies for these key oncology products.
Previous Experience at Pfizer
Before joining Bristol Myers Squibb, Clare Mc Cabe worked at Pfizer. From 2010 to 2012, she served as a Brand Manager in Immunology. Prior to that, she was a Portfolio Specialist in Immunology at Pfizer Australia, from 2007 to 2010. These roles provided her with substantial experience in the field of immunology.
Education and Academic Background
Clare Mc Cabe pursued her undergraduate studies at UWS, achieving a Bachelor of Business Administration in International Business. She attended the university from 1997 to 2000. Her academic background laid a strong foundation for her subsequent career in the pharmaceutical industry.
Career at Bristol Myers Squibb
Clare Mc Cabe began her career at Bristol Myers Squibb in February 2013. She has since advanced to an executive role, focusing on the worldwide commercialization of key oncology products such as Opdivo, Yervoy, and Opdualag. Her work has contributed significantly to the marketing strategies and global outreach of these important cancer therapies.
Industry Experience and Specialization
With over a decade of experience in the pharmaceutical industry, Clare Mc Cabe has extensive expertise in virology, specifically HIV. Her comprehensive understanding of both immunology and virology has positioned her as a skilled professional in the commercialization of pharmaceutical products, particularly in oncology.